Abstract:Background Septal reduction techniques play a pivotal role in mitigating morbidity and mortality among patients with obstructive hypertrophic cardiomyopathy (oHCM). While trans-apical intramyocardial septal radiofrequency ablation (PIMSRA or LIWEN procedure) has shown promise in reducing left ventricular outflow tract (LVOT) gradients and improving symptoms in oHCM patients, it is associated with complications such as cardiac tamponade and atrioventricular block. Objective This study introduces a novel approach for transcatheter radiofrequency ablation of hypertrophic septum via femoral access, utilizing the DragonFire Transcatheter Myocardial Puncture and Radiofrequency Ablation System. We aim to evaluate its safety and medium-term outcomes in patients with oHCM. Methods A prospective, single-center, single-arm study of tf-PIMSRA was conducted in patients with drug-refractory oHCM. Ten patients were enrolled and underwent the procedure under the guidance of transesophageal echocardiography. The primary outcome was 30-day major adverse clinical events, with secondary outcomes including 90-day improvements in outflow obstruction and quality of life. Results All patients, with an average age of 57±10 years, including 4 males, underwent the procedure successfully without any complications, including major adverse clinical events or conduction abnormalities. The average duration of the procedure was 125.2±34.6 minutes, with an average ablation time of 38.69±18.29 minutes and ablation energy of 3.60±1.49KJ. At 90-day follow-up, significant reductions were observed in peak LVOT gradients (resting gradient: from 82.00 [56.00] mmHg to 14.00 [6.25] mmHg; p < 0.001; provoked gradient: from 102.00 [76.25] mmHg to 33.00 [16.50] mmHg; p = 0.002), and interventricular septum thickness (from 22.00 [19.00] mm to 17.00 [15.00] mm; p = 0.002). These improvements were associated with enhancements in NYHA functional classification (from 3.00 [2.75] to 1.00 [1.00]; p < 0.0001), Kansas City Cardiomyopathy Questionnaire scores (from 59.00 [44.50] to 80.00 [77.25]; p < 0.02), 6-minute walk distance (from 441 [400] m to 480 [465] m; p < 0.01), and pro B-type natriuretic peptide levels (from 1738.00 [1113.25] pg/ml to 252.00 [200.00] pg/ml; p = 0.002). All patients achieved New York Heart Association functional class I or II at follow-up. Conclusions Transfemoral PIMSRA appears to be a safe and effective procedure for relieving LVOT obstruction and symptoms in patients with drug-refractory oHCM. These findings support further investigation through randomized clinical trials comparing it with established septal reduction therapies.Patient-Level Outcomes for the trans-fem

Using transseptal technique in ablation of left free wall accessory pathways

Catheter ablation of anteroseptal accessory pathway in the non-coronary aortic sinus.

Application of Swartz Sheath During Mapping and Ablation of Right-Side Accessory Pathway

A Modified Endocardial Radiofrequency Ablation Approach for Hypertrophic Obstructive Cardiomyopathy Guided by Transthoracic Echocardiography: a Case Series

Clinical Observation of the Special Phenomena of Radiofrequency Catheter Ablation in the Left Accessory Pathway

An abnormal left ventricular-atrial perforation after radiofrequency catheter ablation: a case report

Strategy of radiofrequency catheter ablation in special left accessory pathway

Transesophageal Echocardiography during Radiofrequency Atheter Ablation of Atrioventricular Accessory Pathways

New access for radiofrequency catheter ablation of left-sided atrioventricular accessory pathways: safety and efficacy of the transradial approach

Application of Swartz Sheath Vs Standard Sheath for Ablation Right-sided Accessory Pathway

Transradial Catheter Ablation of Left Accessory Pathway in Patient with Severe Chest Deformity

Radiofrequency current catheter ablation in 561 cases with tachyarrhythimas

Catheter Radiofrequency Ablation of Recurrent Para-Hisian Accessary Pathways with Near Zero X-ray Exposure

Catheter ablation of left accessory pathway in the patient with valve replacement

Atrioventricular Reentrant Tachycardia Ablation Performed Via Patent Foramen Ovale

Radiofrequency catheter ablation of epicardial atrioventricular accessory pathway

Segmental radiofrequency ablation of pulmonary vein ostia for patients with refractory paroxysmal atrial fibrillation using multi-slice spiral computed tomography guidance

Radiofrequency Current Catheter Ablation of the Left Atrioventricular Accessory Pathways with Paroxysmal Supraventricular Tachycardia.

Radiofrequency catheter ablation of superior ventricular tachycardia in patients with persistent left superior vena cava

Radiofrequency catheter ablation for accessory pathways associated with congenital heart diseases of Ebstein's anomaly

Trans-femoral transcatheter intramyocardial septal radiofrequency ablation: a novel therapeutic approach for obstructive hypertrophic cardiomyopathy